Cargando…
KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is an aggressive tumor with implacable prognosis. It commonly harbors loss-of-function mutations in BAP1, NF2, CDKN2A and TP53, although their pathogenetic role is still uncertain since these genetic alterations, if isolated, do not cause MPM in m...
Autores principales: | Vannucchi, Margherita, Pennati, Veronica, Mencaroni, Clelia, Defraia, Chiara, Bardhi, Ledi, Castiglione, Francesca, Bellan, Cristiana, Comin, Camilla Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093256/ https://www.ncbi.nlm.nih.gov/pubmed/37046732 http://dx.doi.org/10.3390/cancers15072072 |
Ejemplares similares
-
KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021) -
Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022) -
KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player
por: Trassl, Lilith, et al.
Publicado: (2022) -
Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
por: Ollila, Hely, et al.
Publicado: (2022) -
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)